| Dr Kevin Joseph Roche, MD | |
|
1 Dogwood Dr, Annandale, NJ 08801-3101 | |
| (908) 735-4477 | |
| (908) 735-6532 |
| Full Name | Dr Kevin Joseph Roche |
|---|---|
| Gender | Male |
| Speciality | Radiology - Pediatric Radiology |
| Location | 1 Dogwood Dr, Annandale, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760457436 | NPI | - | NPPES |
| 9019600 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085P0229X | Radiology - Pediatric Radiology | 25MA07495400 (New Jersey) | Primary |
| 2085R0202X | Radiology - Diagnostic Radiology | 25MA07495400 (New Jersey) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kevin Joseph Roche, MD Po Box 5388, Clinton, NJ 08809-0388 Ph: (908) 735-4477 | Dr Kevin Joseph Roche, MD 1 Dogwood Dr, Annandale, NJ 08801-3101 Ph: (908) 735-4477 |
News Archive
The regulation is likely to trigger "stiff resistance" from governors and some members of Congress who fear it will undermine the ability of states to control Medicaid spending.
With a range of diseases, doctors need unique features which they can use to unequivocally identify a patient's illness for an appropriate diagnosis. Scientists therefore search for the biomarkers for an illness or a combination of biomarkers, known as biosignatures, which are as easy as possible to measure.
In a study of narcolepsy patients, researchers at the University of Copenhagen have made an important discovery that could help pave the way for improved treatment of the chronic condition.
Reza Dana, M.D., M.P.H., M.Sc. of Mass. Eye and Ear/Harvard Medical School, was awarded the Research to Prevent Blindness (RPB) Senior Scientific Investigator Award in the amount of $150,000 to support research into the causes, treatment and prevention of blinding diseases.
The Ontario Institute for Cancer Research (OICR) today announced $1.5 million in funding over three years for the development of a new drug by Toronto-based Fluorinov Pharma, Inc. The drug, called FV-162, is a highly potent, orally-delivered small molecule proteasome inhibitor with significant advantages over drugs currently used to treat multiple myeloma and some forms of Non-Hodgkin's lymphoma.
› Verified 7 days ago
Dr. Andrew Loesberg, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Dogwood Drive, Annandale, NJ 08801 Phone: 908-735-4477 Fax: 908-735-6532 | |
Mrs. Laura B. Klein, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Dogwood Drive, Annandale, NJ 08801 Phone: 908-735-4477 Fax: 908-735-6532 | |
Dr. Alice Sprenger, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1 Dogwood Drive, Annandale, NJ 08809 Phone: 908-735-4477 Fax: 908-735-6532 | |
Dr. Mark S. Malzberg, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Dogwood Drive, Annandale, NJ 08801 Phone: 908-735-4477 Fax: 907-735-6532 | |
Dr. Howard S Szikman, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Dogwood Dr, Annandale, NJ 08801 Phone: 908-735-4477 Fax: 908-735-6532 | |
Dr. Thoma H. Woo, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Dogwood Dr, Annandale, NJ 08801 Phone: 908-735-4477 Fax: 908-735-6532 |